Physician profile
Gregory R Ball
NPI 1407985278
$5,592.71
in general payments reported to CMS, 2019-2025
34 companies · $1,559 in 2025
The $1,559 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $313 · 2021: $407 · 2022: $916 · 2023: $736 · 2024: $929 · 2025: $1,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,995 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,995.48 |
| Education | $228.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,140.15 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $548.43 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Actelion Pharmaceuticals US, INC. | $514.16 | 2019-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $505.15 | 2019-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $383.05 | 2020-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $321.85 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.18 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Sanofi-Aventis U.S. LLC | $248.97 | 2022-2025 | |
| Mylan Specialty L.P. | $201.04 | 2019-2024 | Yupelri |
| Philips North America LLC | $180.60 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Insmed, INC. | $179.70 | 2019-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $153.76 | 2022-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $126.96 | 2020-2025 | Winrevair |
| Sunovion Pharmaceuticals INC. | $123.51 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $116.58 | 2021-2025 | Dupixent |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $70.62 | 2025 | Tezspire |
| Verona Pharma, INC. | $52.88 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $52.36 | 2025 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $43.89 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.87 | 2019-2022 | |
| Pulmonx Corporation | $42.03 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Baxter Healthcare | $41.38 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Novartis Pharmaceuticals Corporation | $37.47 | 2022-2023 | |
| Veran Medical Technologies, INC. | $28.15 | 2020 | |
| Mallinckrodt Hospital Products INC. | $20.66 | 2021 | |
| Lilly USA, LLC | $18.94 | 2025 | Zepbound |
| Biotissue Holdings INC. | $17.80 | 2023 | |
| Alexion Pharmaceuticals, INC. | $16.81 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.72 | 2024 | Iovera, Exparel |
| Phathom Pharmaceuticals, INC. | $14.20 | 2025 | Voquezna |
| Shire North American Group INC | $13.86 | 2019 | |
| Vapotherm INC | $13.28 | 2023 | Vapotherm |
| Gilead Sciences, INC. | $13.20 | 2019 | |
| Advanced Respiratory, INC | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.